NCT01520740View on ClinicalTrials.gov

Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema

PHASE4TerminatedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Pulmonary Emphysema
Interventions
DEVICE

Emphysematous Lung Sealant

4 Subsegments treated - 2 each bilaterally

DEVICE

Emphysematous Lung Sealant

4 Subsegments treated - 2 each bilaterally

Trial Locations (13)

10117

Charite Campus Virchow-Klinikum, Berlin

21075

Asklepios Klinik Hamburg-Harburg, Hamburg

23560

Sana Kliniken Luebeck, Lübeck

49100

Carmel Medical Center, Petah Tikva

52621

Chaim Sheba Medical Center, Tel Aviv

81377

Medizinische Klinik und Poliklinik Grosshadern, München

82131

Asklepios Fachkliniken Muenchen - Gauting, Gauting

91120

Hadassah - Hebrew University Medical Center, Jerusalem

93093

Klinikum Donaustauf, Donaustauf

96450

Klinikum Coburg, Coburg

99437

Zentralklinik Bad Berka GmbH, Bad Berka

06120

Universitatsklinikum Halle, Halle

D-69126

Thoraxklinik am Uniklinikum Heidelberg, Heidelberg

Sponsors

Lead Sponsor

Aeris Therapeutics
All Listed Sponsors
lead

Aeris Therapeutics

INDUSTRY

NCT01520740 - Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema | Biotech Hunter | Biotech Hunter